Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

Arjang Djamali; Brenda L. Muth; Jose Torrealba; Debra Bloom; Karen M. Miller; David Lorentzen; Hans W. Sollinger; John D. Pirsch; Joshua D. Mezrich

Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

Arjang Djamali, Brenda L. Muth, Jose Torrealba, Debra Bloom, Karen M. Miller, David Lorentzen, Hans W. Sollinger, John D. Pirsch, Joshua D. Mezrich

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	485-490
Number of pages	6
Journal	Clinical transplants
State	Published - 2009

ASJC Scopus subject areas

General Medicine

Cite this

@article{ef6648d2f6744f4abb088abe5e31de6a,

title = "Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.",

author = "Arjang Djamali and Muth, {Brenda L.} and Jose Torrealba and Debra Bloom and Miller, {Karen M.} and David Lorentzen and Sollinger, {Hans W.} and Pirsch, {John D.} and Mezrich, {Joshua D.}",

year = "2009",

language = "English (US)",

pages = "485--490",

journal = "Clinical transplants",

issn = "0890-9016",

publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

AU - Djamali, Arjang

AU - Muth, Brenda L.

AU - Torrealba, Jose

AU - Bloom, Debra

AU - Miller, Karen M.

AU - Lorentzen, David

AU - Sollinger, Hans W.

AU - Pirsch, John D.

AU - Mezrich, Joshua D.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=77954590756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954590756&partnerID=8YFLogxK

M3 - Article

C2 - 20524320

AN - SCOPUS:77954590756

SN - 0890-9016

SP - 485

EP - 490

JO - Clinical transplants

JF - Clinical transplants

ER -

Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation.

ASJC Scopus subject areas

Other files and links

Cite this